Page not found
Engitix announces strategic collaboration with GSK to advance first-in-class targets for liver fibrosis regression
Engitix, a biotechnology company pioneering extracellular matrix (ECM)-driven drug discovery, today announced a strategic research collaboration and option agreement...
Deora, a new proprietary pen injector platform targeting incretin-based therapies, from Stevanato
Stevanato Group, a leading global provider of drug containment, drug delivery and diagnostic solutions for the pharmaceutical, biotechnology and...
Myricx Bio to be acquired by Novartis to advance next-generation ADC payloads for oncology with novel NMTi platform
Myricx Bio, a UK-headquartered biotech company focusing on the discovery and development of a novel class of payloads for antibody-drug...
Reacta Healthcare receives extended MHRA pharmaceutical manufacturer’s licence and GMP certificate
Reacta Healthcare, a leading developer and manufacturer of pharmaceutical-grade oral food challenge (OFC) products for food allergy diagnostics, has...
BIO-Europe 2026
9-11 November Cologne (Koln), Germany
BIO-Europe is Europe’s largest and longest-running partnering conference for the global biotechnology and biopharma industry....
Sysmex launches HISCL platform, enabling faster, scalable Alzheimer’s blood testing
Independent European studies presented at CTAD 2025 and ADPD2026 confirmed that the HISCL™ p-Tau217 RUO* and the HISCL™ Aβ42/40 ratio are highly accurate...
Alturos Therapeutics advances lead candidate ALT0135, a potentially first-in-class, orally bioavailable small molecule, into IND-enabling studies
Alturos Therapeutics, a biopharmaceutical company focused on developing transformative therapies for neurodegenerative diseases, has announced the advancement of its...
Corxel Pharmaceuticals reports positive top-line results from phase 2 trial of CX11 in obese and overweight US adults
Corxel Pharmaceuticals, a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for patients living with cardiometabolic conditions around the...
Tecan accelerates data-driven lab journey with agentic AI developments powered by NVIDIA
Tecan, a global provider of laboratory automation and solutions, has announced the integration of agentic AI capabilities into its...
GSK announces commencement of tender offer to acquire Nuvalent
GSK has entered an agreement to acquire Nuvalent, a Boston-based clinical-stage biopharmaceutical company focused on creating precisely targeted oncology...
Mabwell receives IND clearance from NMPA for LILRB4/CD3-targeting TCE bispecific antibody 6MW5311
Mabwell, an innovation-driven biopharmaceutical company with a fully integrated industry chain, has announced that the National Medical Products Administration...
Viking Therapeutics announces initiation of phase 1 study to evaluate novel amylin receptor agonist VK3019 in healthy adults
Viking Therapeutics, a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced...